Des Moines, IA (PRWEB) October 30, 2015
Eurofins Food Safety Systems and the Allergen Control Group Inc. (ACG) are proud to announce Eurofins’ induction into the Gluten-Free Certification Program (GFCP) as a newly trained and approved third party auditing and certification company. As a trusted supplier of valuable food safety assessments, Eurofins welcomes the opportunity to expand their capabilities, in order to better serve the food industry. This collaboration is a natural fit for Eurofins and ACG, who both share a common interest in food safety and consumer health.
The GFCP is the leading science-based certification program for brand owners wishing to make a safe and reliable gluten-free product claim and is focused exclusively on annual certification of a site's internal manufacturing and gluten management system to complement end-product testing. The GFCP provides unique gluten-free brand building opportunities in partnership with North America's most credible consumer-facing celiac organizations, the National Foundation for Celiac Awareness (NFCA) in the USA and the Canadian Celiac Association (CCA) in Canada.
Eurofins Food Safety Systems is recognized for its efforts and capabilities in the field of food safety audits. As a certification body licensed to audit in the GFSI benchmarked food safety standards, Eurofins provides value added assessments to manufacturers on a global basis. Participation in this program is another example of Eurofins’ food safety expertise and commitment to brand protection. The Gluten-Free Certification Program is an effective, proactive solution to help prevent recalls and retain customer trust.
“We are thrilled to partner with ACG to provide GFCP Audits to our customers”, said Eurofins’ Food Safety Systems Director, Gary Smith. “This partnership will help the food industry verify their food safety programs, label claims, and meet the customer requirements being placed upon them.”
Paul Valder, President of the Allergen Control Group Inc. (ACG), the owners of the GFCP, believes that “this partnership with Eurofins will provide industry with value and increased customer service by providing more capabilities to bundle food safety audit services together with the GFCP.” Industry will also benefit from increased knowledge, by implementing preventative measures, identifying manufacturing deficiencies and documenting corrective actions, addressing effective gluten controls. A recognized GFCP facility has proven it is capable of managing the risk for potential cross contamination, in products carrying a “gluten-free” label claim. Any manufacturer who provides safe, reliable, gluten-free assurances in a complex regulatory landscape and who can also meet the “special dietary needs” for celiac and gluten sensitive consumers, will win brand protection and customer loyalty.
About Eurofins – a global leader in bio-analysis
Eurofins Scientific is the world leader in food, environment and pharmaceutical products testing. It is also one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.
With 20,000 staff in around 200 laboratories across 38 countries, Eurofins offers a portfolio of over 130,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP). http://www.eurofinsus.com/food-safety
About the Allergen Control Group Inc. (ACG)
The Allergen Control Group Inc. is a privately held corporation which owns and operates the Gluten-Free Certification Program which is endorsed exclusively by the NFCA in the USA and the CCA in Canada. http://www.glutenfreecert.com
About the National Foundation for Celiac Awareness (NFCA)
The National Foundation for Celiac Awareness (NFCA) is a US-based 501(c)(3) non-profit organization that drives diagnoses of celiac disease and other gluten-related disorders and improves the quality of life for those on a lifelong gluten-free diet. For more information, visit http://www.CeliacCentral.org.
About the Canadian Celiac Association (CCA)
The Canadian Celiac Association is the national voice for people who are adversely affected by gluten, and is dedicated to improving diagnosis and quality of life. Based in Mississauga, Ontario with 28 Chapters across the country, its mission includes advocacy, education, research and community support. http://www.celiac.ca
For news media information, please contact:
Kim Knoll, Eurofins
Heather Nelson, Allergen Control Group Inc.
1-866-817-0952 ext. 231
This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgment of Eurofins Scientific as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the data available to the Company as of the date of publication, but no guarantee can be made as to their validity.